HealthSnap Joins the Inc. 5000 Following Three-Year Revenue Growth of 2372% and Rapid, Widespread Remote Care Management Platform Adoption
NEW YORK, Aug. 12, 2025 /PRNewswire/...
Fourth consecutive year of recognition highlights company's sustained growth and legal tech innovation.
LEHI, Utah, Aug. 12, 2025 /PRNewswire/ -- Today, Inc. revealed that NetDocuments,...
BRISBANE, Australia, Aug. 12, 2025 /PRNewswire/ -- One quarter of Australians with life insurance wish they'd taken out their policy earlier in life, according...
Supply chain leaders gathered to experience intelligent technology and envision resilient supply chains.
SINGAPORE, Aug. 12, 2025 /PRNewswire/ -- At a time when global logistics...
Health-ISAC warns of rising cyber threats to Brazil’s healthcare sector, urging better intelligence sharing to protect patient data and infrastructure.
CALGARY, Alberta, Aug. 11, 2025 (GLOBE NEWSWIRE) -- KIC Realty is excited to announce the appointment of Erin Best as the new Director of Agent Development for KIC Realty, bringing her dynamic leadership, relationship-first approach, and proven expertise to further elevate the growth and success of our REALTORS®.
NAPLES, Fla., Aug. 11, 2025 /PRNewswire/ -- Prisidio, the secure digital vault company that helps individuals and families Collect, Protect, and Share their most essential...
Acquisitions Increase Growth Outlook
(in U.S. dollars unless otherwise noted)
TORONTO, Aug. 9, 2025 /PRNewswire/ - "I am very pleased with our record financial results this...
As more women seek revision or removal of breast implants, Dr. Pane offers safe, personalized solutions with long-term, natural-looking results.
NORTH PALM BEACH, Fla., Aug....
GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support solutions.
GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support solutions.